Abstract

Objective To explore the short-term outcome of laparoscopic pancreaticoduodenectomy (LPD) and open pancreaticoduodenectomy (OPD) for pancreatic head cancer. Methods The retrospective cohort study was conducted. The clinicopathological data of 108 patients with pancreatic head cancer who were admitted to the Affiliated Tongji Hospital of Huazhong University of Science and Technology between July 2014 and July 2015 were collected. Among 108 patients, 47 and 61 who respectively underwent LPD and OPD were allocated into LPD and OPD groups. Observation indicators: (1) intraoperative situations; (2) postoperative situations; (3) postoperative pathological situations; (4) follow-up and survival situations. Follow-up using outpatient examination and telephone interview was performed to detect chemotherapy and postoperative survival situations at 1 and 3 years postoperatively up to June 2018. Measurement data with normal distribution were represented as ±s and comparison between groups was analyzed using the t test. Comparison between groups of count data was analyzed using the chi-square test. Results (1) Intraoperative situations: operation time in the LPD and OPD groups was respectively (288±24)minutes and (265±29)minutes, with no statistically significant difference between groups (t=5.138, P>0.05). Volume of intraoperative blood loss in the LPD and OPD groups was respectively (136±14)mL and (388±21)mL, with a statistically significant difference between groups (t=-7.297, P 0.05). (2) Postoperative situations: of 47 patients in the LPD group, 16 with postoperative complications were improved by conservative treatment, including 7 with pancreatic fistula (5 with biochemical pancreatic fistula and 2 with grading B and C of pancreatic fistula); 4 with delayed gastric emptying were cured by gastrointestinal decompression and gastric motility promoting treatment; 2 with postoperative bleeding were improved by conservative treatment; 2 with intra-abdominal infection were improved by enhanced antibiotic therapy and transabdominal percutaneous drainage; 1 with biliary fistula was improved by transabdominal percutaneous drainage; there was no wound infection and perioperative death. Of 61 patients in the OPD group, 28 with postoperative complications were improved by conservative treatment, including 12 with pancreatic fistula (9 with biochemical pancreatic fistula and 3 with grading B and C of pancreatic fistula); 8 with delayed gastric emptying were cured by gastrointestinal decompression and gastric motility promoting treatment; 3 with intra-abdominal infection were improved by enhanced antibiotic therapy and transabdominal percutaneous drainage; 2 with postoperative bleeding were improved by conservative treatment; 2 with wound infection were cured by conservative treatment; 1 with biliary fistula was improved by transabdominal percutaneous drainage; there was no perioperative death. There was no statistically significant difference in the cases with postoperative complications between groups (χ2=1.546, P>0.05). Duration of hospital stay in the LPD and OPD groups was (13.6±2.1)days and (19.3±4.4)days, respectively, with a statistically significant difference (t=-4.354, P 0.05), and there was 1 patient with R1 resection in the OPD group. The total number of lymph node dissected in the LPD and OPD groups was respectively 19±4 and 13±4, with a statistically significant difference (t=-4.126, P 0.05). (4) Follow-up and survival situations: 44 and 55 patients in the LPD and OPD group respectively underwent postoperative adjuvant therapy during the follow-up, with no statistically significant difference (χ2=0, P>0.05). The postoperative 1-year follow-up: 47 patients in the LPD group were followed up, 37 survived and 10 died; of 61 patients in the OPD group, 3 lost to follow-up, and 58 were followed up (43 survived and 15 died); there was no statistically significant difference in survival between groups (χ2=0.301, P>0.05). The postoperative 3-year follow-up: of 47 patients in the LPD group, 3 lost to follow-up, and 44 were followed up (21 survived and 23 died); of 61 patients in the OPD group, 6 lost to follow-up, and 55 were followed up (23 survived and 32 died); there was no statistically significant difference in survival between groups (χ2=0.346, P>0.05). Conclusion LPD is safe and feasible for pancreatic head cancer, with advantages of less bleeding, shorter duration of hospital stay and more total number of lymph node dissected, and its survival effect is equivalent to that of OPD. Key words: Pancreatic neoplasms; Pancreatic head cancer; Pancreaticoduodenectomy; Short-term outcomes; Laparoscopy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call